LogicBio Therapeutics, Inc clinical trials
Acquired by AstraZeneca, Nov 16, 2022 · source ↗
The registry lists 1 studies whose lead sponsor is LogicBio Therapeutics, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 23, 2024.
- 1study on the registry
- 0open to participants now
Before and after it joined AstraZeneca
- First submitted before LogicBio Therapeutics, Inc became part of AstraZeneca
- 1
- First submitted after LogicBio Therapeutics, Inc became part of AstraZeneca
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 1 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Stopped early1100%
Over the years
- 121
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- LogicBio Therapeutics, Inc1 study
Something wrong with this grouping? Tell us on the AstraZeneca page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All AstraZeneca studies →
- Gene Therapy With hLB-001 in Pediatric Patients With Severe Methylmalonic AcidemiaTerminatedNCT04581785Phase 1/2
Sponsor listed in the registry: LogicBio Therapeutics, Inc · First submitted before LogicBio Therapeutics, Inc became part of AstraZeneca